Launched in 2006, ILULU was a €5million project consisting of a team of 5 partners across 3 countries.
Together, they aimed to develop a simple, affordable diagnostic test for tuberculosis (TB) to improve detection of active TB particularly in HIV infected adults, and children. Improved detection can reduce the global burden of transmission and address the key problem of delay in TB diagnosis leading to the increase in morbidity and mortality that characterizes the HIV/TB pandemic in the developing world.
The major objectives of the programme were to:
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 848196